Compare
Alpha PRO Tech Ltd vs Myomo, Inc. vs Sanara MedTech Inc. vs Lifeward Ltd.
| Latest fiscal year | Alpha PRO Tech Ltd APT | Myomo, Inc. MYO | Sanara MedTech Inc. SMTI | Lifeward Ltd. LFWD |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $59.14M | $40.93M | $103.12M | $22.03M |
| Revenue growth (YoY) | +2.3% | +25.7% | +19.0% | -14.1% |
| Gross margin | 38.1% | 65.7% | 92.7% | 38.2% |
| Operating margin | 6.5% | -35.2% | 7.1% | -89.3% |
| Net margin | 6.0% | -38.1% | -36.4% | -90.4% |
| Net income | $3.53M | -$15.57M | -$37.56M | -$19.91M |
| EPS (Diluted) | $0.33 | -$0.37 | -$4.36 | -$17.16 |
| Operating cash flow | $2.37M | -$14.51M | $6.79M | -$16.83M |
| Free cash flow | $1.73M | -$16.25M | $2.16M | -$16.84M |
| Cash & equivalents | $16.99M | $14.13M | $16.58M | $2.17M |
| Total assets | $74.13M | $38.64M | $72.94M | $22.90M |
| Total liabilities | $11.65M | $27.23M | $67.01M | $14.49M |
| Shareholders' equity | $62.48M | $11.40M | $5.94M | $8.41M |
| Return on year-end equity | 5.7% | -136.6% | -632.5% | -236.8% |
| Shares outstanding | 10.13M | 38.47M | 8.95M | 1.52M |
Revenue, most recent five fiscal years
| Fiscal year | Alpha PRO Tech Ltd | Myomo, Inc. | Sanara MedTech Inc. | Lifeward Ltd. |
|---|---|---|---|---|
| Latest | $59.14M Ended 2025-12-31 | $40.93M Ended 2025-12-31 | $103.12M Ended 2025-12-31 | $22.03M Ended 2025-12-31 |
| 1 year earlier | $57.84M Ended 2024-12-31 | $32.55M Ended 2024-12-31 | $86.67M Ended 2024-12-31 | $25.66M Ended 2024-12-31 |
| 2 years earlier | $61.23M Ended 2023-12-31 | $19.24M Ended 2023-12-31 | $64.99M Ended 2023-12-31 | $13.85M Ended 2023-12-31 |
| 3 years earlier | $61.98M Ended 2022-12-31 | $15.56M Ended 2022-12-31 | $45.84M Ended 2022-12-31 | $5.51M Ended 2022-12-31 |
| 4 years earlier | $68.64M Ended 2021-12-31 | $13.86M Ended 2021-12-31 | $24.14M Ended 2021-12-31 | $5.97M Ended 2021-12-31 |